| http://www.w3.org/ns/prov#value | - All subjects met these criteria for the cognitive and behavioral screening.Study DesignThe overall study design was a 2 (age group: younger and older) by 2 (E2 treatment: E2 andplacebo) by 3 (cholinergic challenge drug: 2.5 ??g/kg SCOP, 20 mg MECA, and placebo)design.
|
